Prescribing information

 

       

Icon with text: 5 years of ENTRESTO(TM)

Watch Simon Williams, Patricia Campbell and Jim Moore share their clinical experience with Entresto over the last five years, and their thoughts on what the wealth of clinical trial data for Entresto has meant for them and their patients.

Find out more by watching the video below.

 

Icon of 3 people

Simon Williams is a Consultant Cardiologist at Wythenshawe Hospital, South Manchester and Chair of the British Society for Heart Failure.

Patricia Campbell is a Consultant Cardiologist and Heart Failure Lead at Southern Trust, Northern Ireland.

Jim Moore is a GP with Special Interest in Gloucestershire and President of the Primary Care Cardiovascular Society.

 

Reference     

  1. Entresto European Public Assessment Report.
  2. Entresto Summary of Product Characteristics, 2020.

Rate this content: 
Average: 5 (1 vote)
ENT20-C046(2)a October 2020.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]